• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-620
Medical Device Problem Code Imprecision (1307)
Health Effect - Clinical Code Hypoglycemia (1912)
Date of Event 02/15/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The manufacturer is currently performing an investigation and will provide the results with the supplemental report.
 
Event or Problem Description
On (b)(6) 2023, senseonics was made aware of an incident where the user experienced a hypoglycemia event with no alert asserted by the system due to a sensor inaccuracy.
 
Additional Manufacturer Narrative
Based on the investigation analysis, the reported event on (b)(6) 2023, at 11:33 am est, displayed a temporary mismatch between the sensor reading and calibration entry.The user did not receive a hypoglycemia alert at the time of the event because the sensor reading did not cross the hypoglycemia alert threshold set by the user.Prior to the event, there was a calibration entry of 101 mg/dl at 9:16 am est entered, which closely matched the sensor reading of 101 mg/dl at the time of the reported event.It could not be confirmed if the calibration was performed in error as the subsequent calibration entered at 11:33 am est displayed a mismatch followed by 4 consecutive suspicious calibrations which led the system to go into a sensor suspend phase.In the sensor suspend phase, the system recalibrated its glucose calculation algorithm while the sensor readings were blinded to the user for 6 hours.After the sensor suspend phase, the system re-started in the initialization phase and started displaying better agreement between the sensor readings and fingerstick measurements, with its overall performance within expectations.Although the reported blood glucose (bg) at the time of event was in the normal glucose range, the user took a remedial action by drinking coke and eating grapes.The user did not seek any medical attention.H3.Device evaluated by manufacturer? yes.H6.Investigation findings updated to 114.H6.Investigation conclusions updated to 4315.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Common Device Name
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20875-7005
MDR Report Key16562928
Report Number3009862700-2023-00067
Device Sequence Number5895561
Product Code QHJ
UDI-Device Identifier00817491022936
UDI-Public817491022936
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
P160048
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Expiration Date01/28/2023
Device Model Number102208-620
Device Catalogue NumberFG-5902-01-001
Device Lot Number129004
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/15/2023
Supplement Date Received by Manufacturer02/15/2023
Initial Report FDA Received Date03/17/2023
Supplement Report FDA Received Date04/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/28/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age65 YR
Patient SexFemale
-
-